Taming Autoimmunityโข
cell therapy โข autoimmune โข lupus
51 - 200
๐ฐ $85M Series B on 2022-01
Yesterday
51 - 200
Drive communications strategy at Kyverna Therapeutics, focusing on autoimmune disease therapies. Shape brand narrative and reputation within the organization and in public discourse.
๐บ๐ธ United States โ Remote
๐ต $300k - $400k / year
๐ฐ $85M Series B on 2022-01
โฐ Full Time
๐ด Lead
๐ฃ๏ธ Communications
November 8
51 - 200
Develop engineered T cell-based therapies for autoimmune diseases.
๐บ๐ธ United States โ Remote
๐ต $260k - $350k / year
๐ฐ $85M Series B on 2022-01
โฐ Full Time
๐ Senior
๐จโโ๏ธ Medical Director